Atlas FDA

BD PREPSTAIN SYSTEM

FDA premarket approval P970018/S017 · decided 2009-11-16

Approval details

PMA number
P970018
Supplement
S017
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
BD PREPSTAIN SYSTEM
Generic name
Processor, cervical cytology slide, automated
Applicant
Bd Diagnostic Systems
Date received
2009-06-11
Decision date
2009-11-16
Days to decision
158 days
Decision code
APPR
Product code
MKQ
Advisory committee
Pathology
Expedited review
No
Location
Durham, NC
Statement
APPROVAL FOR A MODIFICATION TO THE INTENDED USE OF THE PREPSTAIN SYSTEM TO ALLOW FOR THE REMOVAL OF A 0.5 ML ALIQUOT OF THE PATIENT SPECIMEN COLLECTED IN THE SUREPATHPRESERVATIVE FLUID COLLECTION VIAL, PRIOR TO PROCESSING WITH THE PREPSTAIN SYSTEM, FOR TESTINGWITH THE BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) QX (CTQ) AND NEISSERIA GONORRHOEAE(GC) QX (GCQ) AMPLIFIED DNA ASSAYS. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THETRADE NAME PREPSTAIN SYSTEM (FORMERLY THE AUTOCYTE PREP SYSTEM) AND IS

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
BD BACTEC FXI Culture System (K260213)BD Diagnostic Systems2026-05-28
PASCO MIC AND MIC/ID PANELS, GEMIFLOXACIN (STREP) (K032518)Bd Diagnostic Systems2003-09-15
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM CEFOTAXIME 0.5-64 UG/ML (K032153)Bd Diagnostic Systems2003-09-11
PASCO MIC AND MIC/ID PANELS (K032259)Bd Diagnostic Systems2003-08-19
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-MEROPENEM 0.25-16 UG/ML (K031429)Bd Diagnostic Systems2003-06-06
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - NORFLOXACIN 0.25 - 16 UG/ML (K030091)Bd Diagnostic Systems2003-02-28